Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's
disease (CD), is characterized by relapse and remission alternately. It remains a great …

Over 1 million residents in the USA and 2.5 million in Europe are estimated to have IBD, with
substantial costs for health care. These estimates do not factor in the'real'price of IBD, which …

Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic
inflammation extending to a variable extent from the rectum. Care of the patient with UC …

This is the second of a series of two articles reporting the European Crohn's and Colitis
Organisation [ECCO] evidence-based consensus on the management of adult patients with …

This article is the second in a series of two publications relating to the European Crohn's and
Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's …

Background & Aims A comprehensive knowledge of the natural history of ulcerative colitis
(UC) helps understand disease evolution, identify poor prognostic markers and impact of …

It is unclear whether ulcerative colitis (UC) is a progressive disease similar to Crohn's
disease (CD). Patients with UC often are undertreated because of the possibility of curative …

Introduction Crohn's disease (CD) and ulcerative colitis (UC) have a progressive course
leading to hospitalisation and surgery. The ability of existing therapies to alter disease …

Objectives: Temporal changes for intestinal resections for Crohn's disease (CD) are
controversial. We validated administrative database codes for CD diagnosis and surgery in …

A subset of patients with ulcerative colitis (UC) present with, or progress to, moderate to
severe disease activity. These patients are at high risk for colectomy, hospitalization …